- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03249545
Late Effect of Ablation on Premature Ventricular Complex Ablation
August 9, 2017 updated by: Fırat Özcan, Yuksek Ihtisas Hospital
Premature Ventricular Complex (PVC) ablation is performed in certain indications.
Generally acutely abolition of PVC at the time of ablation accepted as successful ablation.
However in some patients this effect occurs lately.
In this study investigators sought late effect of ablation
Study Overview
Status
Unknown
Detailed Description
On tissue level ablation lesion deepens and enlarges by time following the procedure.
Based on this, investigators aimed to seek patients who has no acute success but late success.
This phenomenon occurs in some patients.
Investigators investigate the characteristics of those patients on both procedural and clinical aspects.
Investigators enroll patients applied during prespecified dates
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Firat Ozcan, Ass. Prof, MD
- Phone Number: +905327854000
- Email: drfozcan@gmail.com
Study Locations
-
-
-
Ankara, Turkey, 06590
- Recruiting
- Turkiye Yuksek Ihtisas Training and Research Hospital
-
Contact:
- Firat R Ozcan, Ass. Prof, MD
- Phone Number: 5327854000
- Email: drfozcan@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Individuals having premature complexes and matching ablation indications are included and selection will be based on above mentioned criteria
Description
Inclusion Criteria:
Patients who had both of the criteria below
- Presence of premature ventricular complex requiring ablation
- Successfully abolition of premature ventricular complex hours after the procedure
Exclusion Criteria:
Patients who had either of below mentioned criteria
- Abolition of premature ventricular complex during the procedure
- Unsuccessful procedure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success
Time Frame: 3 months
|
Continuation of ablation on the long term
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2017
Primary Completion (Anticipated)
December 31, 2018
Study Completion (Anticipated)
March 1, 2019
Study Registration Dates
First Submitted
August 6, 2017
First Submitted That Met QC Criteria
August 9, 2017
First Posted (Actual)
August 15, 2017
Study Record Updates
Last Update Posted (Actual)
August 15, 2017
Last Update Submitted That Met QC Criteria
August 9, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ozcan02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ablation
-
Mauna Kea TechnologiesCompletedLiver Percutaneous Biopsy or Ablation | Kidney Percutaneous Biopsy or AblationFrance
-
National Taiwan University HospitalRecruitingRadiofrequency AblationTaiwan
-
Acutus MedicalCompletedCatheter AblationUnited States
-
University Hospital, Strasbourg, FranceUnknownPercutaneous Tumor AblationFrance
-
M.D. Anderson Cancer CenterRecruitingLiver Ablation | HepaticUnited States
-
University of Texas Southwestern Medical CenterCompletedCustomized Laser AblationUnited States
-
University Hospital, GrenobleCompletedDrainage | Ablation | Biopsy | PunctionFrance
-
Clear Guide MedicalJohns Hopkins UniversityWithdrawn
-
Raj ShekharNational Cancer Institute (NCI); National Institutes of Health (NIH); IGI Technologies...Completed
-
Philips HealthcareWithdrawnBiopsy or Ablation ProceduresUnited States